Tag: Dr Mahesh Bhalgat
India Unlimited 3.0: Experts say India has the Talent, Tech, and...
With end-to-end capabilities, India is rapidly scaling up its global presence in discovery, development, and manufacturing
“There is a growing trend towards outsourcing clinical trials to India”
Dr Mahesh Bhalgat, Managing Director & Group CEO, Veeda Clinical Research Limited shares his vision for the company, latest developments, long-term growth, industry trends and future outlook
Veeda Clinical Research acquires European CRO ‘Heads’
With this acquisition, Veeda’s global pharmaceutical and biotech clients can now leverage the unique and unparalleled suite of early to late-phase CRO services across Europe, US, and Asia Pacific
Veeda Clinical Research appoints Dr Mahesh Bhalgat as Group CEO
Prior to joining Veeda, Mahesh was the COO for Syngene International (Biocon Group Company), India’s largest CRO & CDMO company
Syngene appoints Dr Mahesh Bhalgat as COO
In a career spanning over 25 years in the field of biotechnology and biologics, Dr Bhalgat is recognized for his contribution to the commercialization of diagnostic kits, biopharmaceuticals and WHO pre-qualification of vaccines.......................